Presentation is loading. Please wait.

Presentation is loading. Please wait.

Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer  S. Gail Eckhardt,

Similar presentations


Presentation on theme: "Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer  S. Gail Eckhardt,"— Presentation transcript:

1 Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer  S. Gail Eckhardt, MD, Peter De Porre, MD, David Smith, MD, Joan Maurel, MD, William P. Steward, MD, Olivier Bouche, MD, Helgi van de Velde, MD, Bart Michiels, PhD, Roland Bugat, MD  Journal of Pain and Symptom Management  Volume 37, Issue 2, Pages (February 2009) DOI: /j.jpainsymman Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

2 Fig. 1 Time to deterioration: a) primary analysis and b) sensitivity analysis. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions


Download ppt "Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer  S. Gail Eckhardt,"

Similar presentations


Ads by Google